Careers  |  Sign In  |  Register  |   Twitter

Latest in Hematology-Oncology

A new leukemia treatment produced by Roche has been approved in Europe, a Reuters article says. The drug, Gazyvaro, is an improved medication for chronic lymphocytic leukemia. Roche aims to transfer as many patients as possible to the new drug, before its predecessor Rituxan is overwhelmed by cheaper...
Advances are being rapidly made in the field of immunotherapy for the treatment of solid tumors. In this free CME, two leading clinicians will discuss studies recently presented on the use of antibodies to programmed death 1 (PD-1), programmed death ligand 1 (PDL-1), and cytotoxic T lymphocyte antigen 4...
A new study in Anesthesia and Analgesia reveals that using a patient's own blood during heart surgery is a safer alternative to the traditional method of blood transfusion. A new entry in the New York Times' Well Blog describes the results of the study, in which the patients who received their own blood...